tesaglitazar regulates hepatic glucose output
Evidence from:
primary |
all sources
Evidence (2 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar did not correct ... the defect in basal HGO
confidence: 0.80
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
tesaglitazar greatly increased insulin's ability to suppress HGO
confidence: 0.90